Expansion readiness Hollister is expanding its footprint in Europe and Northern Europe, including Lithuania and Mayo, Ireland, signaling growing regional demand and potential for additional partnerships, distributors, or direct sales of medical devices and services.

R&D investment Recent €80 million investment in Mayo for R&D and digital transformation indicates a prioritization of innovative product development and enhanced operational capabilities, presenting opportunities to align sales with advanced devices, software solutions, and value-based offerings.

Strategic partnerships New hospice partnerships in Ireland and partnerships with healthcare organizations suggest a channel for expanded clinical applications, training programs, and bundled solutions that address palliative and home-care needs.

Sustainability and governance As an employee-owned company with immutable principles centered on dignity, integrity, stewardship, and service, Hollister may value long-term, ethical partnerships, opportunities to collaborate on patient-centered outcomes, and compliance-driven sales approaches.

Market positioning Revenue in the mid-range (approximately $250M–$500M) with global manufacturing focus and CE marking indicates readiness for global procurement channels, suggesting upsell of accessories, consumables, and service contracts to existing facilities and new EU/UK customers.